Maroni Luca, Haibo Bai, Ray Debolina, Zhou Tianhao, Wan Ying, Meng Fanyin, Marzioni Marco, Alpini Gianfranco
Department of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ancona, Italy.
Scott & White Digestive Disease Research Center, Scott & White, Texas A&M University Health Science Center, Temple, TX 76504.
Cell Mol Gastroenterol Hepatol. 2015 Jul 1;1(4):368-380. doi: 10.1016/j.jcmgh.2015.05.005.
Cholangiocytes are the epithelial cells that line the bile ducts. Along the biliary tree, two different kinds of cholangiocytes exist; small and large cholangiocytes. Each type has important differences in their biological role in physiological and pathological conditions. In response to injury, cholangiocytes become reactive and acquire a neuroendocrine-like phenotype with the secretion of a number of peptides. These molecules act in an autocrine/paracrine fashion to modulate cholangiocyte biology and determine the evolution of biliary damage. The failure of such mechanisms is believed to influence the progression of cholangiopathies, a group of diseases that selectively target biliary cells. Therefore, the understanding of mechanisms regulating cholangiocyte response to injury is expected to foster the development of new therapeutic options to treat biliary diseases. In the present review, we will discuss the most recent findings in the mechanisms driving cholangiocyte adaptation to damage, with particular emphasis on molecular pathways that are susceptible of therapeutic intervention. Morphogenic pathways (Hippo, Notch, Hedgehog), which have been recently shown to regulate biliary ontogenesis and response to injury, will also be reviewed. In addition, the results of ongoing clinical trials evaluating new drugs for the treatment of cholangiopathies will be discussed.
胆管细胞是衬于胆管的上皮细胞。在胆管树中,存在两种不同类型的胆管细胞:小胆管细胞和大胆管细胞。每种类型在生理和病理条件下的生物学作用都有重要差异。在受到损伤时,胆管细胞会发生反应并获得一种神经内分泌样表型,分泌多种肽类。这些分子以自分泌/旁分泌方式发挥作用,调节胆管细胞生物学特性并决定胆管损伤的发展。据信这种机制的失效会影响胆管疾病的进展,胆管疾病是一类选择性靶向胆管细胞的疾病。因此,了解调节胆管细胞对损伤反应的机制有望促进治疗胆管疾病新疗法的开发。在本综述中,我们将讨论胆管细胞适应损伤机制的最新研究结果,特别强调易于进行治疗干预的分子途径。最近已证明可调节胆管发生和对损伤反应的形态发生途径(Hippo、Notch、Hedgehog)也将进行综述。此外,还将讨论评估治疗胆管疾病新药的正在进行的临床试验结果。